A Review on the Effect of Tumor Necrosis Factor Inhibitors on Structural Progression in Early Axial Spondyloarthritis Using Magnetic Resonance Imaging
Journal
Rheumatology and therapy
Journal Volume
6
Journal Issue
2
Pages
139
Date Issued
2019-06
Author(s)
Jois, Ramesh
Lichauco, Juan Javier
Santos Estrella, Paul
Llamado, Lyndon John
Thorat, Amit Vilas
Mahgoub, Ehab
Abstract
Considering the progressive nature of axial spondyloarthritis (axSpA), it is important to determine whether tumor necrosis factor alpha (TNFα) inhibitors have an effect on early inflammatory and structural lesions detected using magnetic resonance imaging (MRI).
Subjects
Adalimumab; Axial spondyloarthritis; Certolizumab; Etanercept; Golimumab; Infliximab; Lesions; Magnetic resonance imaging; Tumor necrosis factor inhibitor
SDGs
Other Subjects
adalimumab; certolizumab pegol; etanercept; golimumab; infliximab; tumor necrosis factor inhibitor; Bath ankylosing spondylitis functional index; bibliographic database; disease course; disease duration; human; medication compliance; nuclear magnetic resonance imaging; population; practice guideline; priority journal; Review; sacroiliac joint; spondylarthritis
Publisher
SPRINGER
Type
review